{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:25:54Z","timestamp":1773260754445,"version":"3.50.1"},"reference-count":38,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2024.j075","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T22:10:46Z","timestamp":1723068646000},"page":"69-81","source":"Crossref","is-referenced-by-count":3,"title":["Long Noncoding LINC00115 Facilitates Cell Growth and Inhibits Apoptosis by Regulating the miR-4701-5p\/P4HB Axis in Bladder Cancer"],"prefix":"10.1620","volume":"265","author":[{"given":"Changyuan","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Bengbu Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Bengbu Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Emergency medicine, The First Affiliated Hospital of Bengbu Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Bengbu Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Bengbu Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaole","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Bengbu Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aghaalikhani, N., Rashtchizadeh, N., Shadpour, P., Allameh, A. &amp; Mahmoodi, M.(2019)  Cancer stem cells as a therapeutic target in bladder cancer.  <i>J. Cell Physiol<\/i>., 234, 3197-3206.","DOI":"10.1002\/jcp.26916"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Alles, J., Fehlmann, T., Fischer, U., Backes, C., Galata, V., Minet, M., Hart, M., Abu-Halima, M., Grasser, F.A., Lenhof, H.P., Keller, A. &amp; Meese, E.(2019)  An estimate of the total number of true human miRNAs.  <i>Nucleic Acids Res<\/i>., 47, 3353-3364.","DOI":"10.1093\/nar\/gkz097"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bellmunt, J.(2015)  Bladder cancer.  <i>Hematol. Oncol. Clin. North Am<\/i>., 29, xiii-xiv.","DOI":"10.1016\/j.hoc.2014.12.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cao, J., Kong, W. &amp; Xiao, X.(2024)  LINC00115 aggravates thyroid cancer progression by targeting miR-489-3p, which downregulates EVA1A to regulate the Hippo signaling pathway.  <i>Heliyon<\/i>, 10, e30331.","DOI":"10.1016\/j.heliyon.2024.e30331"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chandrashekar, D.S., Karthikeyan, S.K., Korla, P.K., Patel, H., Shovon, A.R., Athar, M., Netto, G.J., Qin, Z.S., Kumar, S., Manne, U., Creighton, C.J. &amp; Varambally, S.(2022)  UALCAN: An update to the integrated cancer data analysis platform.  <i>Neoplasia<\/i>, 25, 18-27.","DOI":"10.1016\/j.neo.2022.01.001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chen, L., Heikkinen, L., Wang, C., Yang, Y., Sun, H. &amp; Wong, G.(2019)  Trends in the development of miRNA bioinformatics tools.  <i>Brief Bioinform<\/i>., 20, 1836-1852.","DOI":"10.1093\/bib\/bby054"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Correia de Sousa, M., Gjorgjieva, M., Dolicka, D., Sobolewski, C. &amp; Foti, M.(2019)  Deciphering miRNAs\u2019 Action through miRNA Editing.  <i>Int. J. Mol. Sci<\/i>., 20, 6249.","DOI":"10.3390\/ijms20246249"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dobruch, J. &amp; Oszczud\u0142owski, M.(2021)  Bladder Cancer: Current Challenges and Future Directions.  <i>Medicina<\/i> (<i>Kaunas<\/i>), 57, 749.","DOI":"10.3390\/medicina57080749"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Dyrskj\u00f8t, L., Hansel, D.E., Efstathiou, J.A., Knowles, M.A., Galsky, M.D., Teoh, J. &amp; Theodorescu, D.(2023)  Bladder cancer.  <i>Nat. Rev. Dis. Primers<\/i>., 9, 58.","DOI":"10.1038\/s41572-023-00468-9"},{"key":"#cr-split#-10.1","unstructured":"Guidance, N.(2017) Bladder cancer: diagnosis and management of bladder cancer:"},{"key":"#cr-split#-10.2","doi-asserted-by":"crossref","unstructured":"(c) NICE (2015) Bladder cancer: diagnosis and management of bladder cancer. <i>BJU Int<\/i>., 120, 755-765.","DOI":"10.1111\/bju.14045"},{"key":"11","doi-asserted-by":"crossref","unstructured":"He, X., Xiao, H., Yang, R., Chen, H. &amp; Wang, B.(2021)  lncRNA LOC339524 inhibits the proliferation of bladder cancer cells by targeting the miR-875-5p\/COPS7A signaling axis.  <i>Exp. Ther. Med<\/i>., 22, 1202.","DOI":"10.3892\/etm.2021.10636"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hou, R. &amp; Jiang, L.(2021)  LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt\/beta-catenin pathway through competitively binding to microRNA-30a.  <i>Cancer Cell Int<\/i>., 21, 360.","DOI":"10.1186\/s12935-021-02019-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Jarroux, J., Morillon, A. &amp; Pinskaya, M.(2017)  History, Discovery, and Classification of lncRNAs.  <i>Adv. Exp. Med. Biol<\/i>., 1008, 1-46.","DOI":"10.1007\/978-981-10-5203-3_1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Jiang, B., Hailong, S., Yuan, J., Zhao, H., Xia, W., Zha, Z., Bin, W. &amp; Liu, Z.(2018)  Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.  <i>Biomed. Pharmacother<\/i>., 108, 500-507.","DOI":"10.1016\/j.biopha.2018.09.025"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Kara, G., Calin, G.A. &amp; Ozpolat, B.(2022)  RNAi-based therapeutics and tumor targeted delivery in cancer.  <i>Adv. Drug Deliv. Rev<\/i>., 182, 114113.","DOI":"10.1016\/j.addr.2022.114113"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kong, Y.L., Wang, H.D., Gao, M., Rong, S.Z. &amp; Li, X.X.(2024)  LncRNA XIST promotes bladder cancer progression by modulating miR-129-5p\/TNFSF10 axis.  <i>Discov. Oncol<\/i>., 15, 65.","DOI":"10.1007\/s12672-024-00910-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Li, J.H., Liu, S., Zhou, H., Qu, L.H. &amp; Yang, J.H.(2014)  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.  <i>Nucleic Acids Res<\/i>., 42, D92-97.","DOI":"10.1093\/nar\/gkt1248"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Li, K., Yao, T. &amp; Wang, Z.(2023)  lncRNA-mediated ceRNA network in bladder cancer.  <i>Noncoding RNA Res<\/i>., 8, 135-145.","DOI":"10.1016\/j.ncrna.2022.12.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Li, Y., Luo, S., Dong, W., Song, X., Zhou, H., Zhao, L. &amp; Jia, L.(2016)  Alpha-2, 3-sialyltransferases regulate the multidrug resistance of chronic myeloid leukemia through miR-4701-5p targeting ST3GAL1.  <i>Lab. Invest<\/i>., 96, 731-740.","DOI":"10.1038\/labinvest.2016.50"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Ma, X., Wang, J., Zhuang, J., Ma, X., Zheng, N., Song, Y. &amp; Xia, W.(2020)  P4HB modulates epithelial-mesenchymal transition and the beta-catenin\/Snail pathway influencing chemoresistance in liver cancer cells.  <i>Oncol. Lett<\/i>., 20, 257-265.","DOI":"10.3892\/ol.2020.11569"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Mehmandar-Oskuie, A., Jahankhani, K., Rostamlou, A., Arabi, S., Sadat Razavi, Z. &amp; Mardi, A.(2023)  Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies.  <i>Biomed. Pharmacother<\/i>., 165, 115242.","DOI":"10.1016\/j.biopha.2023.115242"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Mirzayans, R. &amp; Murray, D.(2020)  Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies? <i>Int. J. Mol. Sci.<\/i>, 21, 9090.","DOI":"10.3390\/ijms21239090"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Nagura-Ikeda, M., Imai, K., Tabata, S., Miyoshi, K., Murahara, N., Mizuno, T., Horiuchi, M., Kato, K., Imoto, Y., Iwata, M., Mimura, S., Ito, T., Tamura, K. &amp; Kato, Y.(2020)  Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19.  <i>J. Clin. Microbiol<\/i>., 58, e01438-20.","DOI":"10.1128\/JCM.01438-20"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Peng, N., Zhang, Z., Wang, Y., Yang, M., Fan, J., Wang, Q., Deng, L., Chen, D., Cai, Y., Li, Q., Wang, X. &amp; Li, W.(2021)  Down-regulated LINC00115 inhibits prostate cancer cell proliferation and invasion via targeting miR-212-5p\/FZD5\/Wnt\/beta-catenin axis.  <i>J. Cell Mol. Med<\/i>., 25, 10627-10637.","DOI":"10.1111\/jcmm.17000"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Shao, L., Yu, Q., Lu, X., Zhang, X. &amp; Zhuang, Z.(2021)  Downregulation of LINC00115 inhibits the proliferation and invasion of lung cancer cells in vitro and in vitro.  <i>Ann. Transl. Med<\/i>., 9, 1256.","DOI":"10.21037\/atm-21-3724"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. &amp; Bray, F.(2021)  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.  <i>CA Cancer J. Clin<\/i>., 71, 209-249.","DOI":"10.3322\/caac.21660"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Wang, X., Bai, Y., Zhang, F., Yang, Y., Feng, D., Li, A., Yang, Z., Li, D., Tang, Y., Wei, X., Wei, W. &amp; Han, P.(2020)  Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder.  <i>Onco. Targets Ther<\/i>., 13, 9543-9558.","DOI":"10.2147\/OTT.S267734"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Wolfien, M., Brauer, D.L., Bagnacani, A. &amp; Wolkenhauer, O.(2019)  Workflow Development for the Functional Characterization of ncRNAs.  <i>Methods Mol. Biol<\/i>., 1912, 111-132.","DOI":"10.1007\/978-1-4939-8982-9_5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Wu, B., Xue, X., Lin, S., Tan, X. &amp; Shen, G.(2022)  LncRNA LINC00115 facilitates lung cancer progression through miR-607\/ITGB1 pathway.  <i>Environ. Toxicol<\/i>., 37, 7-16.","DOI":"10.1002\/tox.23367"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Wu, Q., Yang, Z., Shi, Y. &amp; Fan, D.(2014)  MiRNAs in human cancers: the diagnostic and therapeutic implications.  <i>Curr. Pharm. Des<\/i>., 20, 5336-5347.","DOI":"10.2174\/1381612820666140128204914"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Wu, Y., Peng, Y., Guan, B., He, A., Yang, K., He, S., Gong, Y., Li, X. &amp; Zhou, L.(2021)  P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.  <i>Oncol. Lett<\/i>., 21, 95.","DOI":"10.3892\/ol.2020.12356"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Yan, D., Liu, W., Liu, Y. &amp; Zhu, X.(2022)  Circular RNA circ_0065378 upregulates tumor suppressor candidate 1 by competitively binding with miR-4701-5p to alleviate colorectal cancer progression.  <i>J. Gastroenterol. Hepatol<\/i>., 37, 1107-1118.","DOI":"10.1111\/jgh.15862"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Yuan, C., Luo, X., Duan, S. &amp; Guo, L.(2020)  Long noncoding RNA LINC00115 promotes breast cancer metastasis by inhibiting miR-7.  <i>FEBS Open Bio<\/i>., 10, 1230-1237.","DOI":"10.1002\/2211-5463.12842"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Yang, J., Zhang, Q., Xu, Q., Lu, L., Wang, J. &amp; Xia, W.(2019)  P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling.  <i>Mol. Med. Rep<\/i>., 19, 231-237.","DOI":"10.3892\/mmr.2018.9660"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Zhu, J., Huang, Y., Zhang, Y., Huang, R. &amp; Huang, C.(2021)  KCNMB2-AS1 Promotes Bladder Cancer Progression Through Sponging miR-374a-3p to Upregulate S100A10.  <i>Front. Genet<\/i>., 12, 655569.","DOI":"10.3389\/fgene.2021.655569"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Zhu, Q., Tan, J., Zhan, T., Liu, M., Zou, Y. &amp; Liu, W.(2023)  LINC00115 promotes gastric cancer partly by the miR-212-5p\/ATPAF1 axis.  <i>An. Acad. Bras. Cienc<\/i>., 95, e20230480.","DOI":"10.1590\/0001-3765202320230480"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Zou, Z., Li, Z., Sun, W., Gao, W., Liu, B., Liu, J. &amp; Guo, Y.(2023)  Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression.  <i>BMC Urol<\/i>., 23, 167.","DOI":"10.1186\/s12894-023-01331-5"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/265\/2\/265_2024.J075\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:23:05Z","timestamp":1742012585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/265\/2\/265_2024.J075\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j075","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024.J075"}}